Efficacy and safety of daridorexant in Chinese patients with insomnia disorder: a multicenter, randomized, double-blind, placebo-controlled phase III clinical trial.

Huang Z, Wang H, Zhang B, Li C, Wang J, Xu L, Xu Q, Chen J, Xiao L, Wang Z, Wang B, Jiang Y, Liu Y, Yuan C, Ma Q, Wu J, Liu X, Huang Y, Cui H, Wang F, Wang Y

Open source

DOI: 10.1093/sleep/zsaf170
Published: 2025 Dec 11
Container: Sleep
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/sleep/zsaf170,
  title = {Efficacy and safety of daridorexant in Chinese patients with insomnia disorder: a multicenter, randomized, double-blind, placebo-controlled phase III clinical trial.},
  author = {Huang Z and Wang H and Zhang B and Li C and Wang J and Xu L and Xu Q and Chen J and Xiao L and Wang Z and Wang B and Jiang Y and Liu Y and Yuan C and Ma Q and Wu J and Liu X and Huang Y and Cui H and Wang F and Wang Y},
  year = {2025},
  journal = {Sleep},
  doi = {10.1093/sleep/zsaf170},
  url = {https://doi.org/10.1093/sleep/zsaf170}
}

RIS

TY  - JOUR
TI  - Efficacy and safety of daridorexant in Chinese patients with insomnia disorder: a multicenter, randomized, double-blind, placebo-controlled phase III clinical trial.
AU  - Huang Z
AU  - Wang H
AU  - Zhang B
AU  - Li C
AU  - Wang J
AU  - Xu L
AU  - Xu Q
AU  - Chen J
AU  - Xiao L
AU  - Wang Z
AU  - Wang B
AU  - Jiang Y
AU  - Liu Y
AU  - Yuan C
AU  - Ma Q
AU  - Wu J
AU  - Liu X
AU  - Huang Y
AU  - Cui H
AU  - Wang F
AU  - Wang Y
PY  - 2025
JO  - Sleep
DO  - 10.1093/sleep/zsaf170
UR  - https://doi.org/10.1093/sleep/zsaf170
ER  -

APA

Z, H., H, W., B, Z., C, L., J, W., L, X., Q, X., J, C., L, X., Z, W., B, W., Y, J., Y, L., C, Y., Q, M., J, W., X, L., Y, H., H, C., F, W., & Y, W. (2025). Efficacy and safety of daridorexant in Chinese patients with insomnia disorder: a multicenter, randomized, double-blind, placebo-controlled phase III clinical trial.. Sleep. https://doi.org/10.1093/sleep/zsaf170

Source records

pubmed · retrieved 2026-09-26T12:56:23.521Z